These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17982923)

  • 1. Pilot study of the effects of n-3 polyunsaturated fatty acids on exhaled nitric oxide in patients with stable asthma.
    Moreira A; Moreira P; Delgado L; Fonseca J; Teixeira V; Padrão P; Castel-Branco G
    J Investig Allergol Clin Immunol; 2007; 17(5):309-13. PubMed ID: 17982923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge.
    Schubert R; Kitz R; Beermann C; Rose MA; Lieb A; Sommerer PC; Moskovits J; Alberternst H; Böhles HJ; Schulze J; Zielen S
    Int Arch Allergy Immunol; 2009; 148(4):321-9. PubMed ID: 19001792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary intake of α-linolenic acid and low ratio of n-6:n-3 PUFA are associated with decreased exhaled NO and improved asthma control.
    Barros R; Moreira A; Fonseca J; Delgado L; Castel-Branco MG; Haahtela T; Lopes C; Moreira P
    Br J Nutr; 2011 Aug; 106(3):441-50. PubMed ID: 21443816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marine lipid fraction PCSO-524 (lyprinol/omega XL) of the New Zealand green lipped mussel attenuates hyperpnea-induced bronchoconstriction in asthma.
    Mickleborough TD; Vaughn CL; Shei RJ; Davis EM; Wilhite DP
    Respir Med; 2013 Aug; 107(8):1152-63. PubMed ID: 23660397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asthma control test is correlated to FEV1 and nitric oxide in Greek asthmatic patients: influence of treatment.
    Papakosta D; Latsios D; Manika K; Porpodis K; Kontakioti E; Gioulekas D
    J Asthma; 2011 Nov; 48(9):901-6. PubMed ID: 21923284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea.
    Park Y; Lee A; Shim SC; Lee JH; Choe JY; Ahn H; Choi CB; Sung YK; Bae SC
    J Nutr Biochem; 2013 Jul; 24(7):1367-72. PubMed ID: 23333088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and omega-3 polyunsaturated fatty acid supplementation in athletes with exercise-induced bronchoconstriction: a pilot study.
    Price OJ; Hull JH; Howatson G; Robson-Ansley P; Ansley L
    Expert Rev Respir Med; 2015 Jun; 9(3):369-78. PubMed ID: 25864870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary omega-3 polyunsaturated fatty acid supplementation and airway hyperresponsiveness in asthma.
    Mickleborough TD
    J Asthma; 2005 Jun; 42(5):305-14. PubMed ID: 16036405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide.
    Buchvald F; Bisgaard H
    Ann Allergy Asthma Immunol; 2003 Sep; 91(3):309-13. PubMed ID: 14533665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associated demographics of persistent exhaled nitric oxide elevation in treated asthmatics.
    Matsunaga K; Yanagisawa S; Hirano T; Ichikawa T; Koarai A; Akamatsu K; Sugiura H; Minakata Y; Matsunaga K; Kawayama T; Ichinose M
    Clin Exp Allergy; 2012 May; 42(5):775-81. PubMed ID: 22515393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhaled nitric oxide reflects asthma severity and asthma control.
    Delgado-Corcoran C; Kissoon N; Murphy SP; Duckworth LJ
    Pediatr Crit Care Med; 2004 Jan; 5(1):48-52. PubMed ID: 14697108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of exhaled nitric oxide, spirometry and asthma symptoms.
    Spergel JM; Fogg MI; Bokszczanin-Knosala A
    J Asthma; 2005 Dec; 42(10):879-83. PubMed ID: 16393728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.
    Paro-Heitor ML; Bussamra MH; Saraiva-Romanholo BM; Martins MA; Okay TS; Rodrigues JC
    Pediatr Pulmonol; 2008 Feb; 43(2):134-41. PubMed ID: 18085692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide.
    Miraglia del Giudice M; Piacentini GL; Capasso M; Capristo C; Maiello N; Boner AL; Capristo AF
    Respir Med; 2007 Aug; 101(8):1809-13. PubMed ID: 17418554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oil supplementation with a special combination of n-3 and n-6 long-chain polyunsaturated fatty acids does not protect for exercise induced asthma: a double-blind placebo-controlled trial.
    Dreßler M; Fussbroich D; Böhler L; Herrmann E; Benker N; Tytyk M; Schulze J; Schubert R; Beermann C; Zielen S
    Lipids Health Dis; 2020 Jul; 19(1):167. PubMed ID: 32660564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily exhaled nitric oxide measurements and asthma exacerbations in children.
    van der Valk RJ; Baraldi E; Stern G; Frey U; de Jongste JC
    Allergy; 2012 Feb; 67(2):265-71. PubMed ID: 21999328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ciclesonide and fluticasone on exhaled nitric oxide in patients with mild allergic asthma.
    Zietkowski Z; Bodzenta-Lukaszyk A; Tomasiak MM; Szymanski W; Skiepko R
    Respir Med; 2006 Sep; 100(9):1651-6. PubMed ID: 16443353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancy between clinical asthma control assessment tools and fractional exhaled nitric oxide.
    Khalili B; Boggs PB; Shi R; Bahna SL
    Ann Allergy Asthma Immunol; 2008 Aug; 101(2):124-9. PubMed ID: 18727466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant supplementation and exhaled nitric oxide in children with asthma.
    Tenero L; Piazza M; Zanoni L; Bodini A; Peroni D; Piacentini GL
    Allergy Asthma Proc; 2016; 37(1):e8-13. PubMed ID: 26831840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.